Literature DB >> 31029947

Comprehensive review on the interaction between natural compounds and brain receptors: Benefits and toxicity.

Ana R Silva1, Clara Grosso2, Cristina Delerue-Matos3, João M Rocha4.   

Abstract

Given their therapeutic activity, natural products have been used in traditional medicines throughout the centuries. The growing interest of the scientific community in phytopharmaceuticals, and more recently in marine products, has resulted in a significant number of research efforts towards understanding their effect in the treatment of neurodegenerative diseases, such as Alzheimer's (AD), Parkinson (PD) and Huntington (HD). Several studies have shown that many of the primary and secondary metabolites of plants, marine organisms and others, have high affinities for various brain receptors and may play a crucial role in the treatment of diseases affecting the central nervous system (CNS) in mammalians. Actually, such compounds may act on the brain receptors either by agonism, antagonism, allosteric modulation or other type of activity aimed at enhancing a certain effect. The current manuscript comprehensively reviews the state of the art on the interactions between natural compounds and brain receptors. This information is of foremost importance when it is intended to investigate and develop cutting-edge drugs, more effective and with alternative mechanisms of action to the conventional drugs presently used for the treatment of neurodegenerative diseases. Thus, we reviewed the effect of 173 natural products on neurotransmitter receptors, diabetes related receptors, neurotrophic factor related receptors, immune system related receptors, oxidative stress related receptors, transcription factors regulating gene expression related receptors and blood-brain barrier receptors.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Blood-brain barrier; Brain receptors; Natural products; Neuroinflammation; Neuroplasticity; Oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 31029947     DOI: 10.1016/j.ejmech.2019.04.028

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Molecular Dynamics Simulations of Essential Oil Ingredients Associated with Hyperbranched Polymer Drug Carriers.

Authors:  Vasilios Raptis; Kostas Karatasos
Journal:  Polymers (Basel)       Date:  2022-04-26       Impact factor: 4.967

2.  Molecular docking studies of natural immunomodulators indicate their interactions with the CD40L of CD40/CD40L pathway and CSF1R kinase domain of microglia.

Authors:  Shashank Kumar Maurya; Rajnikant Mishra
Journal:  J Mol Model       Date:  2022-03-24       Impact factor: 1.810

Review 3.  Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's Disease.

Authors:  Lidia Ciccone; Jennifer Vandooren; Susanna Nencetti; Elisabetta Orlandini
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-24

Review 4.  Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs.

Authors:  Marianna Tosato; Valerio Di Marco
Journal:  Biomolecules       Date:  2019-07-09

Review 5.  Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.

Authors:  Zefeng Zhao; Xufen Dai; Chenyang Li; Xiao Wang; Jiale Tian; Ying Feng; Jing Xie; Cong Ma; Zhuang Nie; Peinan Fan; Mingcheng Qian; Xirui He; Shaoping Wu; Yongmin Zhang; Xiaohui Zheng
Journal:  Eur J Med Chem       Date:  2019-11-16       Impact factor: 6.514

Review 6.  Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.

Authors:  Maria D Auxtero; Susana Chalante; Mário R Abade; Rui Jorge; Ana I Fernandes
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

7.  Toxicological Evaluation and In Silico Identification of Acetylcholinesterase Inhibitors in a Commercial Polyherbal Formulation (KWAPF01).

Authors:  A Raliat Aladodo; Ibrahim O Ibrahim; Saheed Sabiu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-15       Impact factor: 2.650

Review 8.  An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events.

Authors:  Marika Cordaro; Salvatore Cuzzocrea; Rosalia Crupi
Journal:  Antioxidants (Basel)       Date:  2020-03-05

Review 9.  The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation.

Authors:  Bikram Khadka; Jae-Young Lee; Dong Ho Park; Ki-Taek Kim; Jong-Sup Bae
Journal:  Biomolecules       Date:  2020-10-01

Review 10.  Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.

Authors:  Ishtiaq Ahmed; Saif Ur Rehman; Shiva Shahmohamadnejad; Muhammad Anjum Zia; Muhammad Ahmad; Muhammad Muzammal Saeed; Zain Akram; Hafiz M N Iqbal; Qingyou Liu
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.